Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
[Assessment of severity of neurogenic bowel dysfunction in chronic patients with a simple 1-item questionnaire (PGI-S)].
Contribution of mast cells to injury mechanisms in a mouse model of pediatric traumatic brain injury.
Cerebrospinal fluid levels of neurofilament and tau correlate with brain atrophy in natalizumab-treated multiple sclerosis.
Injectable Disease Modifying Agents in Multiple Sclerosis: Pattern of Medication Use and Clinical Effectiveness.
Hippocampal microstructural damage correlates with memory impairment in clinically isolated syndrome suggestive of multiple sclerosis.
A gut (microbiome) feeling about the brain.
The emerging role of p38 MAP kinase in multiple sclerosis and its models.
Improvement of hemoglobin levels after a switch from intravenous to subcutaneous administration of immunoglobulin in chronic inflammatory demyelinating polyneuropathy and multifocal motor neuropathy.
Glycyrrhizic acid prevents astrocyte death by neuromyelitis optica-specific IgG via inhibition of C1q binding.
Herpes zoster laryngitis in a patient treated with fingolimod.
Physical Activity and Its Correlates in Youth with Multiple Sclerosis.
Evaluating Soluble EMMPRIN as a Marker of Disease Activity in Multiple Sclerosis: Studies of Serum and Cerebrospinal Fluid.
Inadequate outcome measures are the biggest impediment to successful clinical trials in progressive MS - YES.
The importance of a multi-disciplinary perspective and patient activation programmes in MS management.
Effectiveness of minocycline in acute white matter injury after intracerebral hemorrhage.
An oral NaV1.8 blocker improves motor function in mice completely deficient of myelin protein P0.
Immunological processes related to cognitive impairment in MS.
Expression of brain-derived neurotrophic factor in astrocytes - Beneficial effects of glatiramer acetate in the R6/2 and YAC128 mouse models of Huntington's disease.
Heterogeneous depression trajectories in multiple sclerosis patients.
MicroRNA-155 contributes to shear-resistant leukocyte adhesion to human brain endothelium in vitro.
Impact of Exercise on Innate Immunity in Multiple Sclerosis Progression and Symptomatology.
A review of the ethics of the use of placebo in clinical trials for relapsing-remitting multiple sclerosis therapeutics.
Neuromyelitis optica relapses: Race and rate, immunosuppression and impairment.
Haematopoietic stem cell transplantation in autoimmune diseases: From basic science to clinical practice.
Subcutaneous immunoglobulins in the treatment of chronic immune-mediated neuropathies.
Pages
« first
‹ previous
…
769
770
771
772
773
774
775
776
777
…
next ›
last »